Oncotype News

This is selected news for Oncotype, which is filed under Sectors / Healthtech. There are 912 news items for this page. Oncotype is occasionally combined with Kevin Conroy, Mark Stenhouse and EndoPredict in news items.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
9/22/2022 Cost and Clinical Benefits Associated with Oncotype DX® Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands
Cost and Clinical Benefits Associated with Oncotype DX¬AE Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands Abstract Objectives. Patients with early-stage HR+/HER2- N0 breast cancer may receive adjuvant chemotherapy in combination with surgery. However, chemotherapy does not always lead to ...
hindawi.com
9/21/2022 Oncotype Score 34- Invasive Lobular Carcinoma- Level 3 Pleomorphic
I got my Oncotype today and the number came in at 34. They recommended chemo but I have read studies that chemo doesn't really work on Invasive Lobular Carcinoma. Has anyone else had Invasive Lobular with such a high Oncotype? If so, what did you do ...
Mayo Clinic
9/21/2022 Oncotype Score 34- Invasive Lobular Carcinoma- Level 3 Pleomorphic
I got my Oncotype today and the number came in at 34. They recommended chemo but I have read studies that chemo doesn't really work on Invasive Lobular Carcinoma. Has anyone else had Invasive Lobular with such a high Oncotype? If so, what did you do ...
Mayo Clinic
9/21/2022 Oncotype Score 34- Invasive Lobular Carcinoma- Level 3 Pleomorphic
I got my Oncotype today and the number came in at 34. They recommended chemo but I have read studies that chemo doesn't really work on Invasive Lobular Carcinoma. Has anyone else had Invasive Lobular with such a high Oncotype? If so, what did you do ...
Mayo Clinic
9/21/2022 Oncotype Score 34- Invasive Lobular Carcinoma- Level 3 Pleomorphic
I got my Oncotype today and the number came in at 34. They recommended chemo but I have read studies that chemo doesn't really work on Invasive Lobular Carcinoma. Has anyone else had Invasive Lobular with such a high Oncotype? If so, what did you do ...
Mayo Clinic
9/20/2022 Oncotype Score 34- Invasive Lobular Carcinoma- Level 3 Pleomorphic Mayo Clinic
9/20/2022 Oncotype Score 34- Invasive Lobular Carcinoma- Level 3 Pleomorphic Mayo Clinic
9/20/2022 Exact Sciences (EXAS) Cologuard Business Grows Amid Cost Woes | Nasdaq Nasdaq
9/20/2022 Exact Sciences (EXAS) Cologuard Business Grows Amid Cost Woes Yahoo News
9/20/2022 Oncotype Score 34- Invasive Lobular Carcinoma- Level 3 Pleomorphic Mayo Clinic
9/20/2022 Oncotype Score 34- Invasive Lobular Carcinoma- Level 3 Pleomorphic Mayo Clinic
9/20/2022 Looking Ahead in the Treatment of Breast Cancer targetedonc.com
9/20/2022 Oncotype Score 34- Invasive Lobular Carcinoma- Level 3 Pleomorphic Mayo Clinic
9/20/2022 Oncotype Score 34- Invasive Lobular Carcinoma- Level 3 Pleomorphic Mayo Clinic
9/19/2022 Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test in Node-Negative Early Breast Cancer dovepress.com
9/12/2022 Trepidations mixed with gratitude Sophie Bierens de Haan | Sophie’s postcards from a singing journey Medium
9/12/2022 MiRNA expression deregulation correlates with the Oncotype DX® DCIS score biomedcentral.com
9/7/2022 Clinical and Practical Implications of the Breast Cancer Index onclive.com
8/26/2022 Exact Sciences Stock Was Up By 6.45% Today via.news
8/26/2022 MDxHealth Reports Half Year 2022 Results biotechwinners.com
8/26/2022 MDxHealth Reports Half Year 2022 Results pharmaceuticaldaily.com
8/25/2022 Reports Half Year 2022 Results Globe Newswire
8/25/2022 MDxHealth Reports Half Year 2022 Results Yahoo News
8/25/2022 MDxHealth S.A. (ONCOB) MDxHealth Reports Half Year 2022 Results researchpool.com
8/25/2022 Skating Shoes Market to Register USD 836.24 Mn growth during 2026 - Technavio advfn.com